Pathology 2018
Research & Reviews: Journal of Medical and Health Sciences
ISSN: 2319-9865
Page 80
October 08-09, 2018
Edinburgh, Scotland
17
th
International Conference on
Pathology & Cancer
Epidemiology
Objective:
Currently, directly sampled endometrial cytology is
the most common method of screening for endometrial cancer
in Japan. The purpose of this study are as follows: comparison
of the detection rate between endometrial cytology and biopsy
for diagnosis of endometrial cancers, and comparison of the
diagnostic value of conventional and liquid-based preparation for
endometrial cytology.
Materials &Methods:
From 2000 to 2016, a total number of 2,326
patients with endometrial cancer underwent surgery at Cancer
Institute Hospital, Tokyo Japan. Among them, we reviewed
preoperative cytology and biopsy specimens of 1860 cases. The
direct endometrial sampling method was applied for endometrial
cytology.
Results:
The detection rate of endometrial cancers between
cytology and biopsy in all stages was 83.9% and 95.7%
respectively, and in early stage was 79.4% and 90.0% respectively.
There were significant differences between them. Comparison
of the two preparation methods (conventional and liquid-based
preparation). Even though there were some differences between
conventional and liquid-based preparation, our results indicated
that both methods are useful for detecting endometrial cancers.
Conclusions:
Although, there were significant differences
between cytology and biopsy in the detection rates of endometrial
cancers, compared to the endometrial biopsy, endometrial
cytology is easier to insert into the uterine cavity and is less
painful. Therefore endometrial cytology has been used as a
screening for endometrial cancer in Japan. Even though there
were some differences between conventional and liquid-based
cytology, our results indicated that both methods are useful for
detecting endometrial cancers.
yuko.sugiyama@jfcr.or.jpDirectly sampled endometrial cytology for screening of
endometrial cancers
Yuko Sugiyama
and
Katsuhiko Hasumi
Cancer Institute Hospital, Tokyo, Japan
RRJMHS 2018
Volume: 7